In July 2025, Novartis Pharmaceuticals conducted a study is to assess the effect of Iptacopan to prevent conversion of early ...

South Korea: In a post hoc analysis of the randomized PULSAR trial, aflibercept 8 mg demonstrated noninferior visual outcomes ...

Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive ...

Find out how higher dose aflibercept may reduce injection burden while preserving vision in retinal vasculopathy.

Handgrip strength is inversely linked to the incidence of age-related macular degeneration, according to a study published ...

In this video from the American Academy of Ophthalmology meeting, Lejla Vajzovic, MD, discusses updates on home OCT for neovascular age-related macular degeneration.

A clinical trial is investigating whether a stem cell-derived patch can replace disease-damaged cells and restore vision. Age-related macular degeneration is a steadily worsening eye disease and the ...

Kalaris Therapeutics ( ($KLRS) ) just unveiled an announcement. Kalaris Therapeutics announced on December 17, 2025, positive initial data from ...

TH103 showed mean 10-letter gain in visual acuity and rapid, robust anatomic improvement at Month 1, following a single injectionTH103 was ...

Zydus Lifesciences has partnered with Swiss firm Bioeq to commercialise NUFYMCO in the US following FDA approval on December ...

Approaching her 91st birthday, Dame Judi Dench has offered a poignant insight into her worsening eyesight, describing the decline as "crushing". The beloved actress, who was first diagnosed with ...